Clinical Trial Update: A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Children With Achondroplasia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating the efficacy and safety of TransCon CNP compared with placebo in children with achondroplasia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Drugs mentioned

• TransCon CNP (C-type natriuretic peptide prodrug)

Snippet

Sponsor: Ascendis Pharma Growth Disorders A/S | Conditions: Achondroplasia | Phase 2, Phase 3 | Status: COMPLETED